10Feb 2024
Pancreatic enzyme replacement therapy in subjects with exocrine pancreatic insufficiency and diabetes mellitus

Pancreatic enzyme replacement therapy in subjects with exocrine pancreatic insufficiency and diabetes mellitus

In this retrospective study, the effects of Pancreatic Enzyme Replacement Therapy (PERT) initiation on glycemic control in diabetes patients with Exocrine Pancreatic Insufficiency (EPI) were examined. Compared to diabetes patients without PERT, PERT did not significantly alter hypoglycemia frequency or severity overall but tended to reduce frequency in chronic pancreatitis cases. Mild hyperglycemia occurred in 19% of cases post-PERT, with no severe adverse events. Gastrointestinal disorders improved in 80% of PERT-treated subjects versus 20% in controls. PERT initiation appears safe in diabetes with EPI, with potential benefits in reducing gastrointestinal disorders. HbA1c and BMI changes were similar between groups.

  • #endo-diabetology

Like

Save

Share